EAU 2018 Kidney Cancer - Results from #20

Viewing 21-38 of 38 articles

EAU 2018: The role of histologic subtypes in follow-up scheme of postsurgical kidney cancer patients

EAU 2018: Trends and Morbidity for Minimally Invasive vs Open Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma

EAU 2018: Dividing Pathologically Upstaged T3a Renal Cell Carcinoma is Associated with Improved Alignment of Outcomes: A call for TMN Revision

EAU 2018: U-SMART: (UCSD small mass ALT RENAL score tumor diameter) A novel scoring system of preoperative predictors to stratify oncologic risk of small renal masses

EAU 2018: MR Spectroscopy Distinguishes Histologically-diagnosed Kidney Tissue

EAU 2018: Cost Benefit Analysis Favors Sonographic Screening For Renal Tumors

EAU 2018: Survival Analyses of Patients with Metastatic Renal Cancer Treated with Targeted Therapy With or Without Cytoreductive Nephrectomy

EAU 2018: Immediate and Late Complications of Robotic Partial Nephrectomy

EAU 2018: Renal Cancer: Partial Nephrectomy, Immediate and Late Complications – Open Technique

EAU 2018: Renal Cancer: Partial Nephrectomy, Immediate and Late Complications - Laparoscopic

EAU 2018: Does Renal Biopsy Make Sense in View of Tumor Heterogeneity?

EAU 2018: Endoscopic Combined Intrarenal Surgery with Disposable Ureteroscope: Bilateral Synchronous Treatment

EAU 2018: Systematic Review and Meta-Analysis of Adjuvant Therapy after Nephrectomy for High-Risk, Non-Metastatic Renal Cell Carcinoma

EAU 2018: Natural History of Collecting Duct Carcinoma: A Unique Multi-Institutional Study with a Centrally-Reviewed Pathology

EAU 2018: Validation of the IMDC Prognostic Model in Metastatic Renal Cancer at Diagnosis and Investigation of it’s Role in the Prediction of Outcome from Cytoreductive Nephrectomy

EAU 2018: PD-L1 Expression is Associated with Tumor Progression and Poor Prognosis in Xp11.2 Translocation Renal Cell Carcinoma

EAU 2018: High Competing Risks Minimize Real-World Utility of Adjuvant Targeted Therapy in Renal Cell Carcinoma: A Population-Based Analysis

EAU 2018: Surgical Safety of Immediate versus Deferred Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma - SURTIME

1
2